icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
eNq1mF1v2jAUhu/5FVHuSYBC202BamPthtSqjBZt2k1lkkMxc+302OZjv34OoRudHHUYfBnbec+Jz+vHR0kuVk8sWABKKng3bEaNMACeiozyx244vr+qn4cXvVoyJwuys+wsakTNVhikjEjZDYvZaAKEy+j7zfUnMO8Dhr1akIjJHFL1ap1WlEVfiJzdkLxYEyQLQbPgCdRMZN0w12ozGiRSocmitxT4U+YkhSTejuzOzh/au+NJXIj9h6qWgNeEP1pFgTtpphoRuOoTBY8C1xX5njhpUzkCKTSmMCRqNkSxoBlk1hBTwiQ4BZkuszvABQNVBLGKx/P0STqJkzlZjeB5YE/6g5ntq5WqN+rNs9NOs31+2mi1OmdOoXBnq+xVMB8Rpw/NTqfdPjmJgcewZkAcKzMUqAjzVBMq+69t5SkOwvObtc+ozBlZR3OZu24VQWKmAc3h9/chxRfco8ERM3v2jz7XjMV7Zj3ewsJTxgWL+kJzVcGMq5HrRvQFV7Cqrqgb5tRq60UK8niyvwS3I36oJ4ymrkAzyNEg1Xg0qObZ8VDwkUgYoz8WfKM8E0t5fMbs1tRT9vkGk1bRHLPmQ+vd+akpg/MR+mEMVHG7XGoUOcSGPlQeApUBn4pDcWI8aZd6ceSRzLjpcERKGFT0OHVHrhgXvrRk3nzu7wyVE1bRz5f3rub4qgHXd5tHqzTNun/K6gZdHyQ3VqxMfH9jl+fbS/er0c6NmVK5fB/Hy+UymhFZl8TsUjTFI1N95xr113l7uavL3qUko6fUJ+WVt199XM/ZW7f5oR3q9v1tJ2yNoVDDAbUokewNnIPL47P4b3vqLe3hK3b4C7NpJYmigvtqcvTEqngY/U1d+RUaQNxOp7TiT0ilL5O4/AvTqyVx8QemV/sNWHHhIg==
LcHnJe5kFSfCekqx
Listen
